Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats

  • Tan, Xiaobin (Key Laboratory of Delivery Systems of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine) ;
  • Gu, Junfei (Key Laboratory of Delivery Systems of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine) ;
  • Zhao, Bingjie (Key Laboratory of Delivery Systems of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine) ;
  • Wang, Shuyuan (Key Laboratory of Delivery Systems of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine) ;
  • Yuan, Jiarui (Key Laboratory of Delivery Systems of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine) ;
  • Wang, Chunfei (Key Laboratory of Delivery Systems of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine) ;
  • Chen, Juan (Key Laboratory of Delivery Systems of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine) ;
  • Liu, Jiping (Department of Pharmacology, Shaanxi University of Chinese Medicine) ;
  • Feng, Liang (Key Laboratory of Delivery Systems of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine) ;
  • Jia, Xiaobin (Key Laboratory of Delivery Systems of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine)
  • Received : 2014.05.20
  • Accepted : 2014.09.23
  • Published : 2015.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Ginseng, the root of Panax ginseng (PG), is used widely as a herbal medicine to prevent and treat various diseases. Panax ginseng has pharmacological effects on neurodegenerative diseases such as Alzheimer's disease (AD). The present study evaluated the neuroprotective effects of PG and its possible neuroprotective mechanisms in advanced glycation end product (AGE)-induced AD in a rat model. Methods: Advanced glycation end products were injected bilaterally into the CA3 region of the rats' brains. The Morris water maze test and step-down type passive avoidance test were performed to evaluate their memory and cognitive abilities. The oxidation indexes in the hippocampus were detected. Immunohistochemistry was conducted to visualize the receptors for advanced glycation end products (RAGEs) and nuclear factor-kappa-light-chain-enhancer of activated B cell (NF-${\kappa}B$). Results: Behavioral results showed that PG (1 g/kg, 0.5 g/kg, and 0.25 g/kg) significantly shortened the escape latency, remarkably increased the number of crossing times, significantly decreased the number of errors, and prolonged the latency in rats with AGE-induced AD. Panax ginseng also significantly reduced the malondialdehyde level, increased the glutathione content, and increased superoxide dismutase activity in the hippocampus. Panax ginseng significantly decreased the expression of RAGE and NF-${\kappa}B$. The blockade of anti-RAGE antibody could significantly reduce AGE-induced impairments and regulate these expressions. Conclusion: Our results demonstrated that PG significantly inhibits AGE-induced memory impairment and attenuates Alzheimer-like pathophysiological changes. These neuroprotective effects of PG may be associated with the RAGE/NF-${\kappa}B$ pathway. Our results provided the experimental basis for applying PG in preventing and treating AD.

Keywords

References

  1. Wang-Dietrich L, Funke SA, Kuhbach K, Wang K, Besmehn A, Willbold S, Cinar Y, Bannach O, Birkmann E, Willbold D. The amyloid-${\beta}$ oligomer count in cerebrospinal fluid is a biomarker for Alzheimer's disease. J Alzheimers Dis 2013;34:985-94.
  2. Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, Munch G. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol Aging 2011;32:763-77. https://doi.org/10.1016/j.neurobiolaging.2009.04.016
  3. Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D, Sayre LM, Monnier VM, Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 1994;91:5710-4. https://doi.org/10.1073/pnas.91.12.5710
  4. Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, et al. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol 1998;153:1149-55. https://doi.org/10.1016/S0002-9440(10)65659-3
  5. Vicente MH, Outeiro TF. The sour side of neurodegenerative disorders: the effects of protein glycation. J Pathol 2010;221:13-25. https://doi.org/10.1002/path.2682
  6. Pazdro R, Burgess JR. The antioxidant 3H-1,2-dithiole-3-thione potentiates advanced glycation end-product-induced oxidative stress in SH-SY5Y cells. Exp Diabetes Res 2012;2012:137607.
  7. Feng L, Zhu MM, Zhang MH, Wang RS, Tan XB, Song J, Ding SM, Jia XB, Hu SY. Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-$\kappa$B pathway activation in human umbilical vein endothelial cells. J Ethnopharmacol 2013;148:27-36. https://doi.org/10.1016/j.jep.2013.03.035
  8. Wang CY, Xie JW, Xu Y, Wang T, Cai JH, Wang X, Zhao BL, An L, Wang ZY. Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/ RAGE/NF-$\kappa$B pathway in a transgenic mouse model of Alzheimer's disease. Antioxid Redox Signal 2013;19:2024-39. https://doi.org/10.1089/ars.2012.5158
  9. Yin DZ, Liu WF. Carbonyl stress, aging mechanisms, and the up-stream molecular etiology of Alzheimer's disease. Prog Biochem Biophys 2012;39:747-55. https://doi.org/10.3724/SP.J.1206.2012.00316
  10. Nitta H, Matsumoto K, Shimizu M, Ni XH, Watanabe H. Panax ginseng extract improves the performance of aged Fischer 344 rats in radial maze task but not in operant brightness discrimination task. Biol Pharm Bull 1995;18:1286-8. https://doi.org/10.1248/bpb.18.1286
  11. Kennedy DO, Scholey AB. Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav 2003;75:687-700. https://doi.org/10.1016/S0091-3057(03)00126-6
  12. Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord 2008;22:222-6. https://doi.org/10.1097/WAD.0b013e31816c92e6
  13. Kim HJ, Kim P, Shin CY. A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. J Ginseng Res 2013;37:8-29. https://doi.org/10.5142/jgr.2013.37.8
  14. Cho IH. Effects of Panax ginseng in neurodegenerative diseases. J Ginseng Res 2012;36:342-53. https://doi.org/10.5142/jgr.2012.36.4.342
  15. Song XY, Hu JF, Chu SF, Zhang Z, Xu S, Yuan YH, Han N, Liu Y, Niu F, He X, et al. Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3b/tau signaling pathway and the Ab formation prevention in rats. Eur J Pharmacol 2013;710:29-38. https://doi.org/10.1016/j.ejphar.2013.03.051
  16. Quan HY, Kim do Y, Chung SH. Korean red ginseng extract alleviates advanced glycation end product-mediated renal injury. J Ginseng Res 2013;37:187-93. https://doi.org/10.5142/jgr.2013.37.187
  17. Lan Z, Chen L, Fu Q, Ji W, Wang S, Liang Z, Qu R, Kong L, Ma S. Paeoniflorin attenuates amyloid-beta peptide-induced neurotoxicity by ameliorating oxidative stress and regulating the NGF-mediated signaling in rats. Brain Res 2013;1498:9-19. https://doi.org/10.1016/j.brainres.2012.12.040
  18. Li XH, Lv BL, Xie JZ, Liu J, Zhou XW, Wang JZ. AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation. Neurobiol Aging 2012;33:1400-10. https://doi.org/10.1016/j.neurobiolaging.2011.02.003
  19. Shaw KE, Bondi CO, Light SH, Massimino LA, McAloon RL, Monaco CM, Kline AE. Donepezil is ineffective in promoting motor and cognitive benefits after controlled cortical impact injury in male rats. J Neurotrauma 2013;30: 557-64. https://doi.org/10.1089/neu.2012.2782
  20. Lan Z, Liu J, Chen L, Fu Q, Luo J, Qu R, Kong L, Ma S. Danggui-Shaoyao-San ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in d-galactose-induced senescent mice. J Ethnopharmacol 2012;141:386-95. https://doi.org/10.1016/j.jep.2012.02.050
  21. Liu J, Wang S, Feng L, Ma D, Fu Q, Song Y, Jia X, Ma S. Hypoglycemic and antioxidant activities of paeonol and its beneficial effect on diabetic encephalopathy in streptozotocin-induced diabetic rats. J Med Food 2013;16: 577-86. https://doi.org/10.1089/jmf.2012.2654
  22. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300. https://doi.org/10.1093/geronj/11.3.298
  23. Lue LF, Walker DG, Jacobson S, Sabbagh M. Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases. Future Neurol 2009;4:167-77. https://doi.org/10.2217/14796708.4.2.167
  24. Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 2009;87:181-94. https://doi.org/10.1016/j.pneurobio.2009.01.001
  25. Lüth HJ, Ogunlade V, Kuhla B, Kientsch-Engel R, Stahl P, Webster J, Arendt T, Munch G. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cereb Cortex 2005;15:211-20.
  26. Wong A, Luth HJ, Deuther-Conrad W, Dukic-Stefanovic S, Gasic-Milenkovic J, Arendt T, Munch G. Advanced glycation end products co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Res 2001;920: 32-40. https://doi.org/10.1016/S0006-8993(01)02872-4
  27. Neumann A, Schinzel R, Palm D, Riederer P, Munch G. High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Lett 1999;453:283-7. https://doi.org/10.1016/S0014-5793(99)00731-0
  28. Win MT, Yamamoto Y, Munesue S, Saito H, Han D, Motoyoshi S, Kamal T, Ohara T, Watanabe T, Yamamoto H. Regulation of RAGE for attenuating progression of diabetic vascular complications. Exp Diabetes Res 2012;2012: 894605.
  29. Nunomura A. Oxidative stress hypothesis for Alzheimer's disease and its potential therapeutic implications. Rinsho Shinkeigaku 2013;53:1043-5 [in Japanese]. https://doi.org/10.5692/clinicalneurol.53.1043
  30. Edrey YH, Oddo S, Cornelius C, Caccamo A, Calabrese V, Buffenstein R. Oxidative damage and amyloid-${\kappa}$ metabolism in brain regions of the longestlived rodents. J Neurosci Res 2014;92:195-205. https://doi.org/10.1002/jnr.23320
  31. Perrone L, Sbai O, Nawroth PP, Bierhaus A. The complexity of sporadic Alzheimer's disease pathogenesis: the role of RAGE as therapeutic target to promote neuroprotection by inhibiting neurovascular dysfunction. Int J Alzheimers Dis 2012;2012:734956.
  32. Lu JM, Weakley SM, Yang Z, Hu M, Yao Q, Chen C. Ginsenoside Rb1 directly scavenges hydroxyl radical and hypochlorous acid. Curr Pharm Des 2012;18: 6339-47. https://doi.org/10.2174/138161212803832254

Cited by

  1. Salidroside suppresses inflammation in a D-galactose-induced rat model of Alzheimer’s disease via SIRT1/NF-κB pathway vol.31, pp.4, 2015, https://doi.org/10.1007/s11011-016-9813-2
  2. A Role of Ginseng and Its Constituents in the Treatment of Central Nervous System Disorders vol.2016, pp.None, 2015, https://doi.org/10.1155/2016/2614742
  3. Cognitive-Enhancing Herbal Formulae in Korean Medicine: Identification of Candidates by Text Mining and Literature Review vol.22, pp.5, 2016, https://doi.org/10.1089/acm.2015.0257
  4. Neuroprotective effect of formononetin in ameliorating learning and memory impairment in mouse model of Alzheimer’s disease vol.82, pp.1, 2015, https://doi.org/10.1080/09168451.2017.1399788
  5. Role of the Glyoxalase System in Alzheimer’s Disease vol.66, pp.3, 2015, https://doi.org/10.3233/jad-180413
  6. Panax ginseng for Frailty-Related Disorders: A Review vol.5, pp.None, 2015, https://doi.org/10.3389/fnut.2018.00140
  7. Tannins Enriched Fraction of Emblica officinalis Fruits Alleviates High-Salt and Cholesterol Diet-Induced Cognitive Impairment in Rats via Nrf2–ARE Pathway vol.9, pp.None, 2018, https://doi.org/10.3389/fphar.2018.00023
  8. D-ribose is elevated in T1DM patients and can be involved in the onset of encephalopathy vol.11, pp.14, 2015, https://doi.org/10.18632/aging.102089
  9. Enhanced Neuroprotective Effects of Panax Ginseng G115® and Ginkgo Biloba GK501® Combinations In Vitro Models of Excitotoxicity vol.20, pp.23, 2019, https://doi.org/10.3390/ijms20235872
  10. Protective effects against memory impairment induced by methylglyoxal in mice co-treated with FPS-ZM1, an advanced glycation end products receptor antagonist vol.80, pp.4, 2020, https://doi.org/10.21307/ane-2020-033
  11. Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases vol.2020, pp.None, 2020, https://doi.org/10.1155/2020/6565396
  12. Effects of Ginseng on Neurological Disorders vol.14, pp.None, 2015, https://doi.org/10.3389/fncel.2020.00055
  13. Therapeutic Targets for the Treatment of Comorbidities Associated with Epilepsy vol.13, pp.2, 2015, https://doi.org/10.2174/1874467212666191203101606
  14. Panax Ginseng alleviates thioacetamide-induced liver injury in ovariectomized rats: Crosstalk between inflammation and oxidative stress vol.16, pp.11, 2015, https://doi.org/10.1371/journal.pone.0260507